Nanobots Therapeutics
Therapeutics In-Motion
A biomedical company focused on developing and commercializing
MotionTx, a unique proprietary technology platform
COMPANY
Nanobots is a biomedical company focused on developing and commercializing MotionTx technology platform, our proprietary discovery engine for a new class of medicines with unprecedented delivery capabilities.
We’re utilizing MotionTx platform to design, engineer, and develop novel therapeutic candidates with unique properties to cross biological barriers and accumulate in target cells.
Nanobots initial pipeline is focused on oncology and has the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need
The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.
We’re utilizing MotionTx platform to design, engineer, and develop novel therapeutic candidates with unique properties to cross biological barriers and accumulate in target cells.
Nanobots initial pipeline is focused on oncology and has the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need
The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.
SCIENCE
Our science is pioneering the development of MotionTx platform, a new modality of medicines with unique properties to penetrate tissues and accumulate in target cells. What is MotionTx?
New Modality
Novel class of drugs with unique tissue penetration capabilities
Platform Technology
Can carry a variety of drugs for different therapeutic indications
Targeted Delivery
Allow crossing biological barriers and selectively target cells
SCIENTIFIC PUBLICATIONS
Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder
Ana C. Hortelao, Cristina Simó, Maria Guix, Sandra Guallar-Garrido, Esther Julián, Diana Vilela, Luka Rejc, Pedro Ramos-Cabrer, Unai Cossío, Vanessa Gómez-Vallejo, Tania Patiño*, Jordi Llop*, Samuel Sánchez*.
Sci Robot, 2021 Mar 17;6(52)
Enzyme-Powered Gated Mesoporous Silica Nanomotors for On-Command Intracellular Payload Delivery
Antoni Llopis-Lorente, Alba García-Fernández, Nerea Murillo-Cremaes, Ana C. Hortelão, Tania Patiño, Reynaldo Villalonga, Félix Sancenón, Ramón Martínez-Máñez,* and Samuel Sánchez*.
ACS Nano 2019, 13, 12171−12183
Targeting 3D Bladder Cancer Spheroids with Urease-Powered Nanomotors
Ana C. Hortelão, Rafael Carrascosa, Nerea Murillo-Cremaes, Tania Patiño,* and Samuel Sánchez*.
ACS Nano 2019, 13, 429−439
PLATFORM
MotionTx Platform will benefit patients by improving the accumulation of therapeutic drugs in target cells.
TEAM
CLINICAL ADVISORS
Contact
- Parc Cientific Barcelona (PCB)